Qing-Luo-Yin Alleviated Experimental Arthritis in Rats by Disrupting Immune Feedback Between Inflammatory T Cells and Monocytes: Key Evidences from Its Effects on Immune Cell Phenotypes
Open Access
- 1 December 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 7467-7486
Abstract
Background: Qing-Luo-Yin (QLY) is an anti-rheumatic herbal formula. Despite the well-investigated therapeutic efficacy of QLY, its immune regulatory properties are largely unknown. CD4+ T cells and monocytes are two key parameters in rheumatoid arthritis (RA). This study investigated the changes in these cells in QLY-treated RA animal models. Materials and Methods: RA models were induced in male SD rats and were orally treated with QLY. Dynamic metabolic changes in collagen-induced arthritis (CIA) rats were monitored by 1H NMR approach. The immunity profiles of CIA and adjuvant-induced arthritis (AIA) rats were evaluated using immunohistochemical, PCR, ELISA, cytokine chip, flow cytometry, and immunofluorescence experiments. The bioactive components in QLY were identified by bioinformatic-guided LC-MS analyses. The compounds with high abundance in QLY decoction and easily absorbed were taken as key anti-rheumatic components and used to treat blood-derived immune cells using in vitro experiments. Results: The results indicated that QLY decreased Th17 cells frequency and T cells-released IL-6, IL-17 and GM-CSF in CIA rats, which was attributed to the impaired lymphocyte maturation and altered differentiation. QLY inhibited lactic acid production and inflammatory polarization in the monocytes during the peak period of AIA and CIA. AIA monocytes elicited significant increase in Th17 cells counts, IL-6 and IL-1β secretion in co-cultured splenocytes, which was abrogated by QLY. QLY-containing serum suppressed the phosphorylation of JNK and p65 in AIA lymphocyte-stimulated normal monocytes and consequently inhibited iNOS and IL-1β expression as well as IL-6 and IL-1β production. Matrine, sinomenine and sophocarpine were identified as major bioactive compounds in QLY. These identified compounds effectively inhibited the development of inflammatory T cells using concentrations detected in QLY-treated rats. At higher concentrations (20-fold increase), the chemical stimuli significantly suppressed the production of IL-1β in AIA monocytes by inhibiting JNK and p65 pathways. Conclusion: By targeting inflammatory T cells and monocytes as well as disrupting their interplay, QLY improved immune environment in RA models especially during the active stages of disease.Keywords
This publication has 48 references indexed in Scilit:
- An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula,Qing-Luo-YinEvidence-Based Complementary and Alternative Medicine, 2013
- Pyrazinamide Effects on Cartilage Type II Collagen Amino Acid CompositionInternational Journal of Peptides, 2012
- Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcriptionNucleic Acids Research, 2011
- Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markersBlood, 2011
- The Human Serum MetabolomePLOS ONE, 2011
- Cytoscape 2.8: new features for data integration and network visualizationBioinformatics, 2010
- Simultaneous LC Analysis of Five Bioactive Alkaloids in an Anti-Angiogenesis Herbal Formula, Qing-Luo-YinChromatographia, 2008
- IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammationJournal of Clinical Investigation, 2008
- High avidity autoreactive T cells with a low signalling capacity through the T-cell receptor: central to rheumatoid arthritis pathogenesis?Arthritis Research & Therapy, 2008
- The balance of Th1/Th2 cytokines in rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2001